Literature DB >> 27470713

Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.

Patricia Rosa de Araujo1, Aparna Gorthi1, Acarizia E da Silva1, Sonal S Tonapi1, Dat T Vo1, Suzanne C Burns2, Mei Qiao2, Philip J Uren3, Zhi-Min Yuan4, Alexander J R Bishop5, Luiz O F Penalva6.   

Abstract

The conserved RNA-binding protein Musashi1 (MSI1) has been characterized as a stem cell marker, controlling the balance between self-renewal and differentiation and as a key oncogenic factor in numerous solid tumors, including glioblastoma. To explore the potential use of MSI1 targeting in therapy, we studied MSI1 in the context of radiation sensitivity. Knockdown of MSI1 led to a decrease in cell survival and an increase in DNA damage compared to control in cells treated with ionizing radiation. We subsequently examined mechanisms of double-strand break repair and found that loss of MSI1 reduces the frequency of nonhomologous end-joining. This phenomenon could be attributed to the decreased expression of DNA-protein kinase catalytic subunit, which we have previously identified as a target of MSI1. Collectively, our results suggest a role for MSI1 in double-strand break repair and that its inhibition may enhance the effect of radiotherapy.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27470713      PMCID: PMC5012509          DOI: 10.1016/j.ajpath.2016.05.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.

Authors:  Dat T Vo; Mei Qiao; Andrew D Smith; Suzanne C Burns; Andrew J Brenner; Luiz O F Penalva
Journal:  RNA Biol       Date:  2011-09-01       Impact factor: 4.652

Review 2.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

3.  Prognostic value of Musashi-1 in gliomas.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Jørn Herrstedt; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  J Neurooncol       Date:  2013-09-21       Impact factor: 4.130

4.  Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy.

Authors:  Wenzhuo Zhuang; Bingzong Li; Linmei Long; Liesong Chen; Qiang Huang; Zhong-Qin Liang
Journal:  Brain Res       Date:  2010-11-23       Impact factor: 3.252

5.  Correct end use during end joining of multiple chromosomal double strand breaks is influenced by repair protein RAD50, DNA-dependent protein kinase DNA-PKcs, and transcription context.

Authors:  Amanda Gunn; Nicole Bennardo; Anita Cheng; Jeremy M Stark
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

6.  The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.

Authors:  Dat T Vo; Kotb Abdelmohsen; Jennifer L Martindale; Mei Qiao; Kumiko Tominaga; Tarea L Burton; Jonathan A L Gelfond; Andrew J Brenner; Vyomesh Patel; Daniel Trageser; Björn Scheffler; Myriam Gorospe; Luiz O F Penalva
Journal:  Mol Cancer Res       Date:  2012-01       Impact factor: 5.852

7.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.

Authors:  Sripathi M Sureban; Randal May; Robert J George; Brian K Dieckgraefe; Howard L McLeod; Satish Ramalingam; Kumar S Bishnupuri; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

8.  Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.

Authors:  Raquel de Sousa Abreu; Patricia C Sanchez-Diaz; Christine Vogel; Suzanne C Burns; Daijin Ko; Tarea L Burton; Dat T Vo; Soudhamini Chennasamudaram; Shu-Yun Le; Bruce A Shapiro; Luiz O F Penalva
Journal:  J Biol Chem       Date:  2009-03-03       Impact factor: 5.157

9.  Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma.

Authors:  Y Shen; Y Wang; K Sheng; X Fei; Q Guo; J Larner; X Kong; Y Qiu; J Mi
Journal:  Cell Death Dis       Date:  2011-12-08       Impact factor: 8.469

10.  Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.

Authors:  Xiao-Yang Wang; Huina Yu; R Ilona Linnoila; Laodong Li; Dangyu Li; Biwen Mo; Hideyuki Okano; Luiz O F Penalva; Robert I Glazer
Journal:  Oncotarget       Date:  2013-05
View more
  18 in total

Review 1.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

Review 2.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

3.  LINC01094 Down-Regulates miR-330-3p and Enhances the Expression of MSI1 to Promote the Progression of Glioma.

Authors:  Bin Zhu; Wei Liu; Hongliang Liu; Qiang Xu; Wei Xu
Journal:  Cancer Manag Res       Date:  2020-07-28       Impact factor: 3.989

4.  Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.

Authors:  Caihong Yi; Guiming Li; Dmitri N Ivanov; Zhonghua Wang; Mitzli X Velasco; Greco Hernández; Soni Kaundal; Johanna Villarreal; Yogesh K Gupta; Mei Qiao; Christopher G Hubert; Matthew J Hart; Luiz O F Penalva
Journal:  RNA Biol       Date:  2018-11-18       Impact factor: 4.652

5.  Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication.

Authors:  Pavithra L Chavali; Lovorka Stojic; Luke W Meredith; Nimesh Joseph; Michael S Nahorski; Thomas J Sanford; Trevor R Sweeney; Ben A Krishna; Myra Hosmillo; Andrew E Firth; Richard Bayliss; Carlo L Marcelis; Susan Lindsay; Ian Goodfellow; C Geoffrey Woods; Fanni Gergely
Journal:  Science       Date:  2017-06-01       Impact factor: 47.728

Review 6.  RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer.

Authors:  Priya Chatterji; Anil K Rustgi
Journal:  Trends Mol Med       Date:  2018-04-05       Impact factor: 15.272

7.  Evasion of regulatory phosphorylation by an alternatively spliced isoform of Musashi2.

Authors:  Melanie C MacNicol; Chad E Cragle; F Kennedy McDaniel; Linda L Hardy; Yan Wang; Karthik Arumugam; Yasir Rahmatallah; Galina V Glazko; Ania Wilczynska; Gwen V Childs; Daohong Zhou; Angus M MacNicol
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

Review 8.  Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.

Authors:  Mahboobeh Forouzanfar; Liana Lachinani; Kianoush Dormiani; Mohammad Hossein Nasr-Esfahani; Ali Osmay Gure; Kamran Ghaedi
Journal:  Stem Cell Res Ther       Date:  2020-05-24       Impact factor: 6.832

9.  Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.

Authors:  Mitzli X Velasco; Adam Kosti; Gabriela D A Guardia; Marcia C Santos; Allison Tegge; Mei Qiao; Bruna R S Correa; Greco Hernández; Erzsebet Kokovay; Pedro A F Galante; Luiz O F Penalva
Journal:  RNA       Date:  2019-04-19       Impact factor: 4.942

Review 10.  Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.

Authors:  Gayle B Collin; Navdeep Gogna; Bo Chang; Nattaya Damkham; Jai Pinkney; Lillian F Hyde; Lisa Stone; Jürgen K Naggert; Patsy M Nishina; Mark P Krebs
Journal:  Cells       Date:  2020-04-10       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.